Featured Research

from universities, journals, and other organizations

PSA Level Predicts Future Prostate Growth

Date:
February 15, 2000
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
The higher a man's prostate specific antigen (PSA) level is, the more likely his prostate will continue to grow abnormally, researchers at UT Southwestern Medical Center at Dallas report.

DALLAS - February 11, 2000 - The higher a man's prostate specific antigen (PSA) level is, the more likely his prostate will continue to grow abnormally, researchers at UT Southwestern Medical Center at Dallas report.

Dr. Claus Roehrborn and colleagues said in January's Journal of Urology that men with a PSA level of 3.3 nanograms/milliliter or higher have four times the prostate growth rate over four years of men with a PSA level of 1.3 nanograms/milliliter or lower.

"Urologists want to be able to predict whether a man's prostate will grow slowly or quickly so they can recommend appropriate treatment," said Roehrborn. "Our study shows that the best predictor of growth is the PSA level."

The PSA test, the routine indicator of prostate cancer and enlarged prostate, defines prostate volume by measuring the amount of protein produced by prostate cells. If a man's PSA level is high, he has more prostate cells, indicating growth of his prostate.

The prostate, a walnut-sized bundle of glands, surrounds the urethra. If it becomes enlarged, it can restrict urine flow and cause discomfort.

While prostate cancer is one cause of abnormal prostate growth, prostate growth is not always cancerous. An enlarged prostate, benign prostatic hyperplasia (BPH), however, can cause serious urinary problems, including acute urinary retention, which may require surgery.

The study means doctors can make a more accurate prediction of whether a man's prostate growth will continue. If it is likely to grow, doctors might prescribe a drug proven to slow the growth, or if it is unlikely to grow, doctors may choose to monitor the growth but not treat it.

"The PSA test provides the doctor with critical information in planning a treatment," Roehrborn said. "Every man over age 50 should have a PSA test and digital rectal exam annually."


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "PSA Level Predicts Future Prostate Growth." ScienceDaily. ScienceDaily, 15 February 2000. <www.sciencedaily.com/releases/2000/02/000215064404.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2000, February 15). PSA Level Predicts Future Prostate Growth. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/02/000215064404.htm
University Of Texas Southwestern Medical Center At Dallas. "PSA Level Predicts Future Prostate Growth." ScienceDaily. www.sciencedaily.com/releases/2000/02/000215064404.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins